Cargando…
Novel Insights into RAD52’s Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies
SIMPLE SUMMARY: Human RAD52 is a non-essential DNA/RNA-binding protein thought to be involved in many DNA repair mechanisms. Initially regarded as having a major role only in error-prone backup DNA repair mechanisms, RAD52 has recently gained attention because its inhibition induces synthetic lethal...
Autores principales: | Balboni, Beatrice, Rinaldi, Francesco, Previtali, Viola, Ciamarone, Andrea, Girotto, Stefania, Cavalli, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046612/ https://www.ncbi.nlm.nih.gov/pubmed/36980703 http://dx.doi.org/10.3390/cancers15061817 |
Ejemplares similares
-
RAD52 as a Potential Target for Synthetic Lethality-Based Anticancer Therapies
por: Toma, Monika, et al.
Publicado: (2019) -
RAD52: Paradigm of Synthetic Lethality and New Developments
por: Rossi, Matthew J., et al.
Publicado: (2021) -
Synthetic Lethality
in Pancreatic Cancer: Discovery
of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous
Recombination and Synergizes with Olaparib
por: Bagnolini, Greta, et al.
Publicado: (2020) -
Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells
por: Sullivan-Reed, Katherine, et al.
Publicado: (2018) -
Identification of a RAD52 Inhibitor Inducing Synthetic Lethality in BRCA2-Deficient Cancer Cells
por: Yang, Qianye, et al.
Publicado: (2021)